These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
151 related items for PubMed ID: 10796922
1. Retroperitoneal metastases in testicular cancer: role of CT measurements of residual masses in decision making for resection after chemotherapy. Steyerberg EW, Keizer HJ, Sleijfer DT, Fossâ SD, Bajorin DF, Gerl A, de Wit R, Kirkels WJ, Koops HS, Habbema JD. Radiology; 2000 May; 215(2):437-44. PubMed ID: 10796922 [Abstract] [Full Text] [Related]
2. Residual pulmonary masses after chemotherapy for metastatic nonseminomatous germ cell tumor. Prediction of histology. ReHiT Study Group. Steyerberg EW, Keizer HJ, Messemer JE, Toner GC, Schraffordt Koops H, Fosså SD, Gerl A, Sleijfer DT, Donohue JP, Habbema JD. Cancer; 1997 Jan 15; 79(2):345-55. PubMed ID: 9010108 [Abstract] [Full Text] [Related]
3. Validity of predictions of residual retroperitoneal mass histology in nonseminomatous testicular cancer. Steyerberg EW, Gerl A, Fossá SD, Sleijfer DT, de Wit R, Kirkels WJ, Schmeller N, Clemm C, Habbema JD, Keizer HJ. J Clin Oncol; 1998 Jan 15; 16(1):269-74. PubMed ID: 9440752 [Abstract] [Full Text] [Related]
4. Prediction of residual retroperitoneal mass histology after chemotherapy for metastatic nonseminomatous germ cell tumor: multivariate analysis of individual patient data from six study groups. Steyerberg EW, Keizer HJ, Fosså SD, Sleijfer DT, Toner GC, Schraffordt Koops H, Mulders PF, Messemer JE, Ney K, Donohue JP. J Clin Oncol; 1995 May 15; 13(5):1177-87. PubMed ID: 7537801 [Abstract] [Full Text] [Related]
5. Resection of small, residual retroperitoneal masses after chemotherapy for nonseminomatous testicular cancer: a decision analysis. Steyerberg EW, Marshall PB, Keizer HJ, Habbema JD. Cancer; 1999 Mar 15; 85(6):1331-41. PubMed ID: 10189139 [Abstract] [Full Text] [Related]
6. Testicular tumors: residual retroperitoneal mass surgery after chemotherapy;Is it possible to predict their histology? Medina-Polo J, Martínez-Silva V, Domínguez-Esteban M, de la Rosa-Kehrmann F, Villacampa-Aubá F, Castellano-Gauna D, Díaz-González R. Arch Esp Urol; 2011 Sep 15; 64(7):611-9. PubMed ID: 21965259 [Abstract] [Full Text] [Related]
7. Teratoma in primary testis tumor reduces complete response rates in the retroperitoneum after primary chemotherapy. The case for primary retroperitoneal lymph node dissection of stage IIb germ cell tumors with teratomatous elements. Rabbani F, Gleave ME, Coppin CM, Murray N, Sullivan LD. Cancer; 1996 Aug 01; 78(3):480-6. PubMed ID: 8697394 [Abstract] [Full Text] [Related]
8. Validation of a prediction model and its predictors for the histology of residual masses in nonseminomatous testicular cancer. Vergouwe Y, Steyerberg EW, Foster RS, Habbema JD, Donohue JP. J Urol; 2001 Jan 01; 165(1):84-8; discussion 88. PubMed ID: 11125370 [Abstract] [Full Text] [Related]
9. Residual abdominal masses after chemotherapy for nonseminomatous testicular cancer: correlation of CT and histology. Stomper PC, Jochelson MS, Garnick MB, Richie JP. AJR Am J Roentgenol; 1985 Oct 01; 145(4):743-6. PubMed ID: 3875994 [Abstract] [Full Text] [Related]
10. Incidence of metastatic nonseminomatous germ cell tumor outside the boundaries of a modified postchemotherapy retroperitoneal lymph node dissection. Carver BS, Shayegan B, Eggener S, Stasi J, Motzer RJ, Bosl GJ, Sheinfeld J. J Clin Oncol; 2007 Oct 01; 25(28):4365-9. PubMed ID: 17906201 [Abstract] [Full Text] [Related]
11. Tumor marker levels in post-chemotherapy cystic masses: clinical implications for patients with germ cell tumors. Beck SD, Patel MI, Sheinfeld J. J Urol; 2004 Jan 01; 171(1):168-71. PubMed ID: 14665869 [Abstract] [Full Text] [Related]
14. Clinical and radiological correlation of retroperitoneal metastasis from nonseminomatous testicular cancer treated with chemotherapy. Dexeus FH, Shirkhoda A, Logothetis CJ, Chong C, Sella A, Ogden S, Swanson D. Eur J Cancer Clin Oncol; 1989 Jan 01; 25(1):35-43. PubMed ID: 2920767 [Abstract] [Full Text] [Related]
15. Nonseminomatous germ cell tumors: assessing the need for postchemotherapy contralateral pulmonary resection in patients with ipsilateral complete necrosis. Besse B, Grunenwald D, Fléchon A, Caty A, Chevreau C, Culine S, Théodore C, Fizazi K. J Thorac Cardiovasc Surg; 2009 Feb 01; 137(2):448-52. PubMed ID: 19185168 [Abstract] [Full Text] [Related]
17. [Limitations of tumor marker surveillance after chemotherapy in advanced non-seminomatous testicular tumors]. Behrendt H, Ringert RH, Pfeiffer R, Homann W, Hartung R. Urol Int; 1983 Feb 01; 38(5):307-9. PubMed ID: 6195793 [Abstract] [Full Text] [Related]
18. Residual masses after chemotherapy for metastatic testicular cancer: the clinical implications of the association between retroperitoneal and pulmonary histology. Re-analysis of Histology in Testicular Cancer (ReHiT) Study Group. Steyerberg EW, Donohue JP, Gerl A, Toner GC, Schraffordt Koops H, Fosså SD, Keizer HJ. J Urol; 1997 Aug 01; 158(2):474-8. PubMed ID: 9224327 [Abstract] [Full Text] [Related]